Why the study?
The molecular basis of MyBP-C's functional impact on skeletal muscle contractility remains uncertain, complicated by fast- and slow-type isoform expression across different muscle types.
Fast- and slow-type MyBP-C isoforms differentially modulate skeletal muscle contractility, providing a molecular basis for fine-tuning mechanical performance.
Answers are grounded in this paper and cite their sources.
Skeletal MyBP-C isoforms differentially tune fast- versus slow-twitch contractility; extends molecular understanding but leaves open therapeutic targeting in myopathies.
Significance Myosin-binding protein C (MyBP-C) is a critical component of the skeletal muscle sarcomere, muscle’s smallest contractile unit. MyBP-C’s importance is evident by genetic mutations leading to human myopathies, such as distal arthrogryposis (i.e., club foot). However, the molecular basis of MyBP-C’s functional impact on skeletal muscle contractility is far from certain. Complicating matters further is the expression of fast- and slow-type MyBP-C isoforms that depend on whether the muscle is fast- or slow-twitch. Using multiscale proteomic, biophysical, and mathematical modeling approaches, we defined the expression, localization, and modulatory capacities of these distinct skeletal MyBP-C isoforms in rat skeletal muscles. Each MyBP-C isoform modulates muscle contractility differentially, providing the capacity to fine-tune a muscle’s mechanical performance as physiological demands arise.
No takes yet. Share an insight, caveat, or question.
Li et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: